Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 57.62%21.8M | -13.26%31.52M | -31.62%13.83M | -32.91%36.33M | -30.29%20.22M | 55.20%54.15M | 86.50%29.01M | 74.02%34.89M | 85.38%15.56M | -62.31%20.05M |
| Operating income | 57.62%21.8M | -13.26%31.52M | -31.62%13.83M | -32.91%36.33M | -30.29%20.22M | 55.20%54.15M | 86.50%29.01M | 74.02%34.89M | 85.38%15.56M | -62.31%20.05M |
| Cost of sales | -424.12%-15.45M | 16.75%-13.31M | 51.09%-2.95M | 30.76%-15.99M | 57.37%-6.03M | -142.91%-23.1M | -156.39%-14.14M | 14.99%-9.51M | 16.20%-5.52M | 20.06%-11.18M |
| Operating expenses | -424.12%-15.45M | 16.75%-13.31M | 51.09%-2.95M | 30.76%-15.99M | 57.37%-6.03M | -142.91%-23.1M | -156.39%-14.14M | 14.99%-9.51M | 16.20%-5.52M | 20.06%-11.18M |
| Gross profit | -41.68%6.35M | -10.52%18.2M | -23.35%10.88M | -34.51%20.34M | -4.54%14.2M | 22.35%31.06M | 48.11%14.87M | 186.29%25.39M | 454.70%10.04M | -77.38%8.87M |
| Selling expenses | 12.74%-4.42M | 3.22%-10.23M | 18.75%-5.07M | -2.50%-10.58M | -48.93%-6.24M | -10.30%-10.32M | 4.60%-4.19M | 17.58%-9.35M | 40.54%-4.39M | 43.28%-11.35M |
| Administrative expenses | 31.06%-9.62M | 32.48%-23.52M | 14.84%-13.95M | -15.48%-34.84M | -33.61%-16.39M | -1.64%-30.17M | 0.91%-12.26M | -18.65%-29.68M | -1.07%-12.38M | 47.61%-25.02M |
| Profit from asset sales | -1,818.84%-3.97M | ---186K | ---207K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | ---- | 100.38%2K | ---- | 39.22%-527K | ---- | -127.22%-867K | ---- | --3.19M | ---- | ---- |
| -Changes in the fair value of financial assets | ---- | 100.38%2K | ---- | ---527K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -127.22%-867K | ---- | --3.19M | ---- | ---- |
| Impairment and provision | -102.41%-7K | 126.39%1.74M | 2,178.57%291K | -21,913.33%-6.6M | 66.67%-14K | -123.44%-30K | -120.39%-42K | 203.23%128K | 98.08%206K | 88.30%-124K |
| -Impairment of intangible assets | ---- | ---- | ---- | ---442K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -102.41%-7K | 128.29%1.74M | 2,178.57%291K | -20,440.00%-6.16M | 66.67%-14K | -123.44%-30K | -120.39%-42K | 203.23%128K | 98.08%206K | 88.30%-124K |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---421K | ---- | ---- | ---- |
| Special items of operating profit | 38.14%891K | 188.94%1.64M | 1.74%645K | -184.01%-1.84M | -27.71%634K | -50.45%2.2M | 24.22%877K | -31.45%4.43M | -81.73%706K | -28.29%6.46M |
| Operating profit | -45.48%-10.79M | 63.71%-12.36M | 5.07%-7.41M | -318.70%-34.05M | -568.09%-7.81M | -37.60%-8.13M | 79.90%-1.17M | 72.07%-5.91M | 58.02%-5.82M | -2.68%-21.16M |
| Financing cost | -7.02%-61K | -104.48%-137K | -67.65%-57K | 87.59%-67K | ---34K | 53.08%-540K | ---- | 8.80%-1.15M | -7.64%-592K | -13.08%-1.26M |
| Share of profits of associates | ---- | ---- | ---- | ---2.12M | ---2.12M | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -45.19%-10.85M | 65.52%-12.49M | 25.04%-7.47M | -317.87%-36.24M | -752.52%-9.97M | -22.82%-8.67M | 81.75%-1.17M | 68.51%-7.06M | 55.51%-6.41M | -3.22%-22.43M |
| Tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.76%16K | -89.19%16K | -75.65%66K |
| After-tax profit from continuing operations | -45.19%-10.85M | 65.52%-12.49M | 25.04%-7.47M | -317.87%-36.24M | -752.52%-9.97M | -23.09%-8.67M | 81.71%-1.17M | 68.49%-7.05M | 55.16%-6.39M | -4.21%-22.36M |
| Earning after tax | -45.19%-10.85M | 65.52%-12.49M | 25.04%-7.47M | -317.87%-36.24M | -752.52%-9.97M | -23.09%-8.67M | 81.71%-1.17M | 68.49%-7.05M | 55.16%-6.39M | 38.41%-22.36M |
| Minority profit | ---- | ---- | ---- | -270.79%-304K | -120.38%-304K | 178.13%178K | 857.36%1.49M | -68.47%64K | ---197K | 108.04%203K |
| Profit attributable to shareholders | -45.19%-10.85M | 65.23%-12.49M | 22.68%-7.47M | -306.03%-35.93M | -263.10%-9.66M | -24.49%-8.85M | 57.04%-2.66M | 68.49%-7.11M | 56.55%-6.19M | 33.20%-22.56M |
| Basic earnings per share | -45.12%-0.0238 | 65.19%-0.0275 | 23.00%-0.0164 | -298.99%-0.079 | -255.00%-0.0213 | -24.53%-0.0198 | 56.83%-0.006 | 68.51%-0.0159 | 56.43%-0.0139 | 33.20%-0.0505 |
| Diluted earnings per share | -45.12%-0.0238 | 65.19%-0.0275 | 23.00%-0.0164 | -298.99%-0.079 | -255.00%-0.0213 | -24.53%-0.0198 | 56.83%-0.006 | 68.51%-0.0159 | 56.43%-0.0139 | 33.20%-0.0505 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants | -- | Hong Kong Lixin Dehao Certified Public Accountants | -- | Hong Kong Lixin Dehao Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.